Nomura Holdings Inc. Acquires Shares of 103,610 Boston Scientific Corporation (BSX)

Nomura Holdings Inc. acquired a new position in shares of Boston Scientific Corporation (NYSE:BSX) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 103,610 shares of the medical equipment provider’s stock, valued at approximately $2,872,000.

A number of other hedge funds also recently added to or reduced their stakes in BSX. BlackRock Inc. boosted its position in Boston Scientific Corporation by 2,181.6% during the first quarter. BlackRock Inc. now owns 95,744,545 shares of the medical equipment provider’s stock worth $2,381,169,000 after purchasing an additional 91,548,235 shares during the period. Janus Henderson Group PLC boosted its position in Boston Scientific Corporation by 22,491.6% during the second quarter. Janus Henderson Group PLC now owns 38,862,599 shares of the medical equipment provider’s stock worth $1,077,270,000 after purchasing an additional 38,690,577 shares during the period. Jennison Associates LLC boosted its position in Boston Scientific Corporation by 405.3% during the second quarter. Jennison Associates LLC now owns 10,639,290 shares of the medical equipment provider’s stock worth $294,921,000 after purchasing an additional 8,533,655 shares during the period. MARSHALL WACE ASIA Ltd bought a new position in Boston Scientific Corporation during the first quarter worth $149,859,000. Finally, Marshall Wace North America L.P. bought a new position in Boston Scientific Corporation during the first quarter worth $149,859,000. 90.44% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/2957528/nomura-holdings-inc-acquires-shares-of-103610-boston-scientific-corporation-bsx.html.

In other news, SVP John Bradley Sorenson sold 7,900 shares of Boston Scientific Corporation stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $26.37, for a total transaction of $208,323.00. Following the completion of the sale, the senior vice president now owns 21,680 shares in the company, valued at approximately $571,701.60. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Timothy A. Pratt sold 10,000 shares of Boston Scientific Corporation stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $26.67, for a total value of $266,700.00. Following the sale, the executive vice president now owns 195,846 shares of the company’s stock, valued at approximately $5,223,212.82. The disclosure for this sale can be found here. In the last 90 days, insiders sold 531,297 shares of company stock valued at $15,144,095. 0.74% of the stock is owned by corporate insiders.

Boston Scientific Corporation (NYSE:BSX) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $0.32 EPS for the quarter, topping the consensus estimate of $0.31 by $0.01. Boston Scientific Corporation had a return on equity of 23.62% and a net margin of 9.04%. The business had revenue of $2.26 billion during the quarter, compared to the consensus estimate of $2.21 billion. During the same quarter last year, the company earned $0.27 EPS. The firm’s revenue was up 6.2% compared to the same quarter last year.

BSX has been the subject of a number of research analyst reports. BidaskClub cut shares of Boston Scientific Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, August 26th. Stifel Nicolaus lifted their price objective on shares of Boston Scientific Corporation from $30.00 to $32.00 and gave the stock a “hold” rating in a research report on Wednesday, June 28th. Oppenheimer Holdings, Inc. set a $29.00 price objective on shares of Boston Scientific Corporation and gave the stock a “hold” rating in a research report on Friday, July 28th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $31.00 price objective on shares of Boston Scientific Corporation in a research report on Friday, September 1st. Finally, Needham & Company LLC reissued a “buy” rating and issued a $32.00 target price on shares of Boston Scientific Corporation in a research report on Tuesday, October 3rd. One analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. Boston Scientific Corporation has an average rating of “Buy” and an average target price of $30.13.

Boston Scientific Corporation Company Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Institutional Ownership by Quarter for Boston Scientific Corporation (NYSE:BSX)

Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.